Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Texas Health Presbyterian Hospital Dallas located at 8200 Walnut Hill Lane, Dallas, TX, 75231 & includes data from NPIs 1255412789, 1245311695, 1396779948
Dexur analyzed Q3 2019 (July to September 2019) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Texas Health Presbyterian Hospital Dallas compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,753 | 1,695 | ||||||||||
| Surgical | 605 | 597 | ||||||||||
| Non Surgical | 1,148 | 1,098 | ||||||||||
| Cardiovascular | 364 | 349 | ||||||||||
| Orthopedics | 252 | 250 | ||||||||||
| General Medicine | 214 | 194 | ||||||||||
| Gastroenterology & Endocrinology | 175 | 171 | ||||||||||
| General Surgery | 164 | 163 | ||||||||||
| Neurology | 154 | 147 | ||||||||||
| Pulmonology | 113 | 108 | ||||||||||
| Urology | 112 | 111 | ||||||||||
| Oncology & Hematology | 65 | 65 | ||||||||||
| Psychiatry & Mental Disorders | 63 | 60 | ||||||||||
| Spine | 20 | 20 | ||||||||||
| Colorectal | 18 | 18 | ||||||||||
| Dermatology | 14 | 14 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 13 | 13 | ||||||||||
| Obstetrics & Gynecology | 12 | 12 |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| Other Cardiothoracic Procedures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Medical Back Problems | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cholecystectomy | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Disorders Of Biliary Tract |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| Extracranial Procedures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Seizures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Jul 2019 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |